Disclaimer
The alfapump® system is not currently approved in the United States or Canada. In the United States and Canada, the alfapump® system is currently under clinical investigation (POSEIDON Study) and is being studied in adult patients with refractory or recurrent ascites due to cirrhosis. For more information regarding the POSEIDON clinical study see www.poseidonstudy.com. The DSR® therapy is still in development and it should be noted that any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed. There is no link between the DSR® therapy and ongoing investigations with the alfapump® system in Europe.
Sequana Medical NV
Kortrijksesteenweg 1112 box 102
9051 Sint-Denijs-Westrem
Swiss Authorized Representative (CH-REP)
Sequana Medical NV
Technoparkstrasse 1
Building Darwin, 2nd floor
8005 Zurich
Sequana Medical GmbH
Rundfunkplatz 2
80335 München
For enquiries or to request information material, please use the contact form below.
United Kingdom
0800 069 84 89
Switzerland
+41 44403 55 29